Researchers have found that children born to mothers who take antiseizure medications during pregnancy may face increased risks of neurodevelopmental conditions. A study involving over three million children from the UK and Sweden has shown that exposure to certain antiseizure drugs like valproate, topiramate, and carbamazepine can lead to specific neurodevelopmental issues. However, the absolute risk of these outcomes is low. The study contrasts earlier findings by not linking topiramate or levetiracetam with ADHD in children. The researchers suggest that individualized decisions about antiseizure medication use during pregnancy should be made with the guidance of a healthcare provider to minimize risks.
Source link
Antiseizure medications during pregnancy linked to neurodevelopmental risks in children
